Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm

Drugs introduced over the past 25 years have benefitted many patients with acute myeloid leukemia (AML) and provided cure for some. Still, AML remains difficult to treat, and most patients will eventually die from their disease. Therefore, novel drugs and drug combinations are under intense investig...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Walter, Roland B., Appelbaum, Frederick R., Tallman, Martin S., Weiss, Noel S., Larson, Richard A., Estey, Elihu H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2010
Schlagworte:
Perspectives
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2953881/
https://ncbi.nlm.nih.gov/pubmed/20538802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-05-285387
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge